Blood test for hidden stomach cancer spread
Part of Cancer, Digestive system clinical trials.
This study tests a new blood test that uses machine learning to find hidden stomach cancer spread (peritoneal metastases) early. It could help people with locally advanced stomach cancer avoid unnecessary surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to give permission to join the study.
- You have been diagnosed with locally advanced stomach cancer (cancer that hasn't spread far).
- You can provide blood samples at specific times during the study.
- Your overall health should be good enough to walk around and take care of yourself (ECOG score 0-2).
- You cannot have cancer that has spread to other organs (like the liver or lungs).
- You must not have had other cancers in the past 5 years (except certain skin or cervical cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to look for signs of stomach (gastric) cancer early. It may help detect cancer before symptoms appear, potentially improving treatment success.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
This study is testing a new way to find stomach (gastric) cancer early using a simple blood test. It may help people who have just been diagnosed with stage I, II, or III stomach cancer and have not started treatment yet.
This study uses a blood test to look for cancer DNA to predict whether stomach, colon, or pancreatic cancer might spread inside the belly before surgery. Early detection of this risk could help doctors plan better treatment.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
This study is looking for proteins in the blood that could help find stomach cancer earlier. It compares people with stomach cancer, people with pre-cancerous stomach changes, and healthy volunteers.
Hear when a new 1. Locally Advanced Gastric Cancer (LAGC): The Primary Condition Under Investigation is Locally Advanced Gastric Cancer, Which Refers to Stomach trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.